Northpoint prides itself on ethical, effective and caring practices in addiction recovery.
So we contracted Milliman - One of the world’s largest and most reputable companies that provide objective analytical and actuarial services.
We are one of the 1st addiction treatment centers to seek out, complete and share the results of an intensive Milliman study to assess our program and success rates.
During the 1950s, Milliman & Robertson established the first health insurance benchmarking tool for the US healthcare market. Milliman produces economic indexes for the American healthcare and insurance markets, including the Milliman 100 Pension Funding index.Print These Slides
The report analyses 3 key behaviors (outcomes) of a group of patients who received substance addiction treatment at Northpoint’s inpatient facility between May 2015 and August 2018. All patients were tracked for a year immediately after finishing their inpatient treatment.
Patients in the study received detox and/or rehabilitation services at Northpoint’s inpatient facility and used Northpoint’s services for outpatient/continued* treatment after discharge from May 2015 through August 2018.
*Outpatient services provided at the Ashwood Location
The most commonly used substances identified for patients admitted to Northpoint between May 2015 and August 2018 were alcohol (51%), opioids (28%), and stimulants (13%)*
The detox and rehab program at Northpoint Seattle is an all-encompassing solution to drug and alcohol addiction treatment. Our inpatient program lasts a few weeks with several weeks or months of outpatient care after discharge
Offers full-time accommodation at our facility while patients undergo rigorous addiction treatment and therapy
Patients completing the inpatient program were less likely to be readmitted within a year of treatment
Patients receive round the clock professional medical support
Patients with longer stays at Northpoint were less likely to have non-compliant urinalysis results compared to patients with shorter stays
The key measurements used to assess the outcomes of treatment patients received at Northpoint were:
How many patients returned to Inpatient Care at Northpoint after being discharged (completing treatment or voluntarily leaving)
How long patients used the services at our Outpatient Treatment Facility at Ashwood Recovery (continuing care) once they had left the Inpatient Care facility at Northpoint
How many patients failed a drug test because one or more substances were found in their urine
Compared to other patients, those who stayed 22 days or more in the Inpatient Program:
Had lower readmission rates: Fewer had to go back to Inpatient treatment after leaving
Spent more time using our Outpatient Therapy services
Had higher rates of compliance with the urine drug test
Patients 18 to 24 years old had higher readmission rates than older age groups
There were no clear differences in rates of noncompliant urinalysis by patient age, sex, or insurance coverage
Patients were given urine drug tests in specific time periods:
0-30 Days | 31-90 Days | 91-180 Days | 181-270 Days | 271-365 Days
However, of patients tested between 181 and 270 days after discharge, 75% of them passed the drug test
Of all the patients in the study who were readmitted to the inpatient program at Northpoint:
Every patient is referred to outpatient services when they leave Northpoint’s Inpatient Program
21% of Northpoint patients made use of outpatient follow-up therapy at the Ashwood outpatient facility for at least 30 days after leaving Northpoint
More than a few weeks
Compared to patients with shorter stays, longer stay patients were:
In general, compared to shorter stay patients, longer stay patients were also:
More likely to continue with outpatient care
Less likely to fail a urine drug test
Comparing the results of patients who stayed 7 days or less in inpatient care to those who stayed for a few weeks or more
Over half of patients admitted to Northpoint were admitted for both residential and detoxification treatment - These patients had the best results
Vivitrol helped patients to avoid relapse and readmission
As part of Northpoint’s treatment program, patients may be given Vivitrol to help prevent relapse
Naltrexone is used primarily to help prevent relapse to opioid dependence after detox and to treat alcohol dependence.
Had lower 30-day, 60-day, and 180-day readmission rates
Were less likely to fail the urine drug test
Were more likely to use outpatient follow-up care
Northpoint has an alumni Facebook group and app available for current and former patients
At Northpoint, we pride ourselves on having a strong alumni program where we continue to engage and connect alumni who have gone through any of our treatment programs
These supportive interactions include a private facebook page, in-person events, surveys, an e-newsletter and an app for phones. We believe, and our data supports, that those who participate in our alumni program are more likely to have long-term success
Participation in Ashwood’s Outpatient Services After Leaving Northpoint’s Inpatient Program